{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:07:31Z","timestamp":1778922451778,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-05973"],"award-info":[{"award-number":["2018-05973"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["12\/IA\/1667"],"award-info":[{"award-number":["12\/IA\/1667"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.xcrm.2022.100804","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T10:43:28Z","timestamp":1667558608000},"page":"100804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-3838","authenticated-orcid":false,"given":"Jamie A.","family":"Sugrue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Posseme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Pou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Charbit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Bondet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nollaig M.","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petter","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darragh","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliona","family":"O\u2019Farrelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100804_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.gene.6364090","article-title":"Host genetic determinants in hepatitis C virus infection","volume":"5","author":"Yee","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.xcrm.2022.100804_bib2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2022.100804_bib3","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2017.07.034","article-title":"Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s","volume":"67","author":"Garvey","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2022.100804_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1423-0410.1999.7630138.x","article-title":"Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation","volume":"76","author":"Lawlor","year":"1999","journal-title":"Vox Sang."},{"key":"10.1016\/j.xcrm.2022.100804_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.26644","article-title":"Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infection","volume":"59","author":"Wiese","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2022.100804_bib6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/jvh.12720","article-title":"Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users","volume":"24","author":"Shawa","year":"2017","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.xcrm.2022.100804_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jvh.12568","article-title":"Anti-envelope antibody responses in individuals at high risk of hepatitis C virus who resist infection","volume":"23","author":"Swann","year":"2016","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.xcrm.2022.100804_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.47.6.845","article-title":"The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985","volume":"47","author":"Yee","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2022.100804_bib9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cid\/cix1071","article-title":"Massive iatrogenic outbreak of human immunodeficiency virus type 1 in rural Cambodia, 2014\u20132015","volume":"66","author":"Rouet","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100804_bib10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100804_bib11","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2022.100804_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2893.2011.01574.x","article-title":"Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection","volume":"19","author":"Warshow","year":"2012","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.xcrm.2022.100804_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2014.05.013","article-title":"Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users","volume":"61","author":"Sugden","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2022.100804_bib14","doi-asserted-by":"crossref","first-page":"e0238347","DOI":"10.1371\/journal.pone.0238347","article-title":"Natural killer cell phenotype is altered in HIV-exposed seronegative women","volume":"15","author":"Zhao","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100804_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clim.2017.09.019","article-title":"Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center study","volume":"183","author":"Duffy","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib16","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s00125-020-05179-4","article-title":"Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes","volume":"63","author":"Rodrigues","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2022.100804_bib17","article-title":"Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses","author":"Llibre","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100804_bib18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1136\/gutjnl-2015-310239","article-title":"Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection","volume":"66","author":"Fischer","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2022.100804_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gut.49.3.423","article-title":"The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection","volume":"49","author":"Barrett","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2022.100804_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/pathogens11030306","article-title":"Uncovering resistance to hepatitis C virus infection: scientific contributions and unanswered questions in the Irish anti-D cohort","volume":"11","author":"Sugrue","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.xcrm.2022.100804_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jhep.2019.04.017","article-title":"Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: a systematic review and meta-analysis","volume":"71","author":"Ji","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2022.100804_bib22","doi-asserted-by":"crossref","first-page":"aaa0698","DOI":"10.1126\/science.aaa0698","article-title":"Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome","volume":"348","author":"Xu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100804_bib23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/infdis\/jit270","article-title":"Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study","volume":"208","author":"Heller","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100804_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2022.100804_bib25","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.celrep.2016.08.011","article-title":"Standardized whole-blood transcriptional profiling enables the deconvolution of complex induced immune responses","volume":"16","author":"Urrutia","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100804_bib26","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons \u03b1 and \u03bb inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2022.100804_bib27","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100804_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.gastro.2017.04.021","article-title":"Tumor necrosis factor inhibits spread of hepatitis C virus among liver cells, independent from interferons","volume":"153","author":"Laidlaw","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2022.100804_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1189\/jlb.1102577","article-title":"Expression and function of chemokines during viral infections: from molecular mechanisms to in\u00a0vivo function","volume":"74","author":"Melchjorsen","year":"2003","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2022.100804_bib30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2022.100804_bib31","doi-asserted-by":"crossref","first-page":"e18322","DOI":"10.1371\/journal.pone.0018322","article-title":"IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100804_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100804_bib33","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1086\/428128","article-title":"Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy","volume":"40","author":"Toyoda","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100804_bib34","doi-asserted-by":"crossref","first-page":"720952","DOI":"10.3389\/fimmu.2021.720952","article-title":"Sex differences in immunity to viral infections","volume":"12","author":"Jacobsen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2022.100804_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/gut.2005.078147","article-title":"Higher clearance of hepatitis C virus infection in females compared with males","volume":"55","author":"Bakr","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2022.100804_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12026-012-8303-9","article-title":"The influence of pregnancy on systemic immunity","volume":"54","author":"Pazos","year":"2012","journal-title":"Immunol. Res."},{"key":"10.1016\/j.xcrm.2022.100804_bib38","doi-asserted-by":"crossref","first-page":"575197","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12026-014-8577-1","article-title":"Risk factors of systemic lupus erythematosus flares during pregnancy","volume":"60","author":"Jara","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.xcrm.2022.100804_bib40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1172\/JCI123623","article-title":"CD4+ T\u00a0cell restoration and control of hepatitis C virus replication after childbirth","volume":"130","author":"Coss","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100804_bib41","doi-asserted-by":"crossref","first-page":"e0186213","DOI":"10.1371\/journal.pone.0186213","article-title":"Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy","volume":"12","author":"Burchill","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100804_bib42","doi-asserted-by":"crossref","first-page":"e07916","DOI":"10.7554\/eLife.07916","article-title":"Bystander hyperactivation of preimmune CD8+ T\u00a0cells in chronic HCV patients","volume":"4","author":"Alanio","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.xcrm.2022.100804_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41590-020-00817-w","article-title":"Memory-like HCV-specific CD8(+) T\u00a0cells retain a molecular scar after cure of chronic HCV infection","volume":"22","author":"Hensel","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/jiab048","article-title":"Long-lasting imprint in the soluble inflammatory Milieu despite early treatment of acute symptomatic hepatitis C","volume":"226","author":"Khera","year":"2022","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100804_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/eji.202149457","article-title":"Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment","volume":"52","author":"Du","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41467-017-02611-z","article-title":"A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100804_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri.2016.125","article-title":"Human immune system variation","volume":"17","author":"Brodin","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib48","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2011.04.005","article-title":"A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection","volume":"141","author":"Knapp","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2022.100804_bib49","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/ncomms6699","article-title":"Reduced IFN\u03bb4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes","volume":"5","author":"Terczy\u0144ska-Dyla","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100804_bib50","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/infdis\/jir647","article-title":"IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association","volume":"204","author":"Shebl","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100804_bib51","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1038\/s41467-021-25218-x","article-title":"Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T\u00a0cell responses","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100804_bib52","doi-asserted-by":"crossref","first-page":"E790","DOI":"10.3390\/jcm9030790","article-title":"Hepatitis C virus: evading the intracellular innate immunity","volume":"9","author":"Ferreira","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.xcrm.2022.100804_bib53","first-page":"1590653","article-title":"Association of toll-like receptor 3 single-nucleotide polymorphisms and hepatitis C virus infection","volume":"2017","author":"Al-Anazi","year":"2017","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.xcrm.2022.100804_bib54","doi-asserted-by":"crossref","first-page":"134529","DOI":"10.1172\/JCI134529","article-title":"TLR3 controls constitutive IFN-\u03b2 antiviral immunity in human fibroblasts and cortical neurons","volume":"131","author":"Gao","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100804_bib55","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1128\/JVI.01125-09","article-title":"Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells","volume":"83","author":"Wang","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100804_bib56","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1038\/s41598-021-94624-4","article-title":"Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients","volume":"11","author":"Menezes","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2022.100804_bib57","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.0000000000000999","article-title":"TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk","volume":"83","author":"Lim","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2022.100804_bib58","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.1102179","article-title":"A common polymorphism in TLR3 confers natural resistance to HIV-1 infection","volume":"188","author":"Sironi","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib59","doi-asserted-by":"crossref","first-page":"757249","DOI":"10.3389\/fimmu.2021.757249","article-title":"Type I interferon and the spectrum of susceptibility to viral infection and autoimmune disease: a shared genomic signature","volume":"12","author":"Sugrue","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.coviro.2015.09.007","article-title":"Epstein-Barr virus latency: current and future perspectives","volume":"14","author":"Kempkes","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2022.100804_bib61","doi-asserted-by":"crossref","first-page":"663664","DOI":"10.3389\/fimmu.2021.663664","article-title":"Latent CMV infection is associated with lower influenza virus-specific memory T-cell frequencies, but not with an impaired T-cell response to acute influenza virus infection","volume":"12","author":"van den Berg","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib62","doi-asserted-by":"crossref","first-page":"eabd4250","DOI":"10.1126\/science.abd4250","article-title":"Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity","volume":"370","author":"Shrock","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100804_bib63","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41590-018-0105-3","article-title":"Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors","volume":"19","author":"Patin","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2022.100804_bib64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aay6485","article-title":"Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens","volume":"366","author":"Mina","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100804_bib65","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.immuni.2014.03.002","article-title":"Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli","volume":"40","author":"Duffy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100804_bib66","doi-asserted-by":"crossref","first-page":"155533","DOI":"10.1016\/j.cyto.2021.155533","article-title":"Differential levels of IFN\u03b1 subtypes in autoimmunity and viral infection","volume":"144","author":"Bondet","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2022.100804_bib67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures Database Hallmark gene Set\u00a0collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122003639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122003639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:14:19Z","timestamp":1778919259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122003639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2666379122003639"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100804","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100804"}}